ÖÜ¿¯ 1997Äê1Ô´´¿¯£¨×ܵÚ323ÆÚ£© µÚ12¾í µÚ15ÆÚ 2008Äê4ÔÂ8ÈÕ³ö°æ


´óÊó¾±¶¯ÂöÇòÄÒËðÉ˾ֲ¿A20»ùÒòתȾºóÄÚÆ¤Ï¸°ûÔÙÉú¼°
Ѫ¹Ü³¬Î¢½á¹¹µÄÓ°Ïì*¡î

¸ß ¾²£¬Àî ÀÙ£¬Ðì µ¤£¬³Â Á¼£¬Çú Åô


¿ÎÌâ±³¾°£ºÐ¿Ö¸µ°°×A20Ϊ½üÄêÀ´ÔÚϸ°ûÄÚÔ´ÐÔ±£»¤»úÖÆµÄÑо¿Öз¢ÏÖµÄÒ»Ààеĵ°°×ÖÊ£¬ÊǺËÒò×Ó¦ÊBÐźÅϵͳ»î»¯µÄ²úÎ²¢¸º·´À¡ÒÖÖÆºËÒò×Ó¦ÊBµÄ»î»¯¶ø¶Ôϸ°ûËðÉËÆð±£»¤×÷Óá£Ëæ×ŶÔѪ¹ÜÄÚÆ¤Ï¸°ûÔöÉú·Ö×ÓÉúÎïѧ»úÖÆµÄÉîÈëÈÏʶºÍ·Ö×ÓÉúÎïѧ¼¼ÊõµÄ·¢Õ¹£¬»ùÒòÖÎÁÆÓпÉÄܳÉΪδÀ´½â¾öÕâÒ»ÎÊÌâµÄÍ»ÆÆµãÖ®Ò»¡£

ͬÐÐÆÀ¼Û£ºÎÄÕ±¨¸æÁËA20»ùÒòתȾ¶ÔÇòÄÒËðÉËѪ¹ÜÄÚÆ¤Ï¸°û¼°Æ½»¬¼¡µÄÓ°Ï죬½á¹û±íÃ÷£¬A20»ùÒòתȾ¿ÉÒÔ¸ÄÉÆËðÉ˲¿Î»ÄÚÆ¤µÄÐÞ¸´ºÍÄæ×ªËðÉËÒýÆðµÄƽ»¬¼¡Ï¸°û±íÐÍת»¯£¬¿ÉÄܶԷÀÖξ­Æ¤¹Ú×´¶¯ÂöÖ§¼ÜÖ²ÈëºóѪ¹ÜÄÚÆ¤Ï¸°ûÔöÉúÖÂÔÙÏÁÕ­ÓÐÒ»¶¨×÷Óã¬ÎÄÕÂÓÐÒ»¶¨µÄ´´ÐÂÐÔ¡£

Ïà¹ØÁ´½Ó£º´óÁ¿ÊµÑéÑо¿·¢ÏÖ£¬ÍêÕûµÄÄÚÆ¤²ãÄÜÒÖÖÆÆ½»¬¼¡Ï¸°ûÔöÉú¡¢Ç¨ÒƼ°Ï¸°ûÍâ»ùÖʺϳɡ£ÄÚÆ¤°þÍÑÔì³ÉÐÂÉúÄÚĤÔöºñ¡£Ö§¼ÜÖÃÈ벿λµÄÔçÆÚÄÚÆ¤»¯¿ÉÄÜÔ¤·ÀѪ˨ÐγɺÍÔÙÏÁÕ­¡£Ñо¿ÕßÃÇÔøÊÔÓöàÖÖ²»Í¬·½°¸£¬°üÀ¨Ò©Îïµ÷¿Ø£¬×éÖ¯¹¤³Ì¡¢»ùÒòºÍ¸Éϸ°ûÖÎÁÆ£¬ÉõÖÁ²Ù×÷·½·¨µÄ¸Ä½ø£¨¼´Ö±½ÓÖÃÈëÖ§¼Ü£©ÒÔÆÚÏÞÖÆÄÚÆ¤ËðÉË£»²¹³äÄÚÆ¤²úÎï¡¢¼ÓËÙÄÚÆ¤Ï¸°ûÔÙÉú£»»òÈý¹ÜÆëÏ£¬ÒÔÆÚ¼õÉÙÐÂÉúÄÚĤÔöºñ¡£×îΪÌìÈ»µÄ;¾¶Ó¦¸Ã»¹ÊǴ̼¤ÔÙÄÚÆ¤»¯£¬´Ù½øÓúºÏ¹ý³ÌµÄ¼ÓËÙ¡£

ÕªÒª
Ä¿µÄ£ºÐ¿Ö¬µ°°×A20ÊǺËÒò×Ó¦ÊBÐźÅϵͳ»î»¯µÄ²úÎï¡£Ñо¿Ö¤ÊµºËÒò×Ó¦ÊBµÄ¼¤»îÊÇÇòÄÒËðÉ˶¯ÂöºóѪ¹ÜÏÁÕ­·¢ÉúµÄÖØÒª»úÖÆÖ®Ò»¡£ÊµÑéÄâ¹Û²ìпָµ°°×A20¶Ô´óÊó¾±×ܶ¯ÂöÇòÄÒËðÉ˾ֲ¿Ñª¹ÜÄÚÆ¤ÔÙÉúºÍѪ¹Ü³¬Î¢½á¹¹µÄÓ°Ïì¡£
·½·¨£ºÊµÑéÓÚ2006-03/2007-06ÔÚ´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÖÐÐÄʵÑéÊÒÍê³É¡£¢ÙʵÑé²ÄÁÏ£º½¡¿µÐÛÐÔSD´óÊó42Ö»£¬ÌåÖÊÁ¿350~400 g¡£¢Ú·Ö×鼰ʵÑé¹ý³Ì£º²ÉÓÃËæ»úÊý×Ö±í·¨½«´óÊó·ÖΪ3×飬ÿ×é14Ö»¡£ÖƱ¸A20ÖÊÁ£DNA£¬½¨Á¢´óÊó¾±×ܶ¯ÂöÇòÄÒËðÉËÄ£ÐÍ£¨¼ÙÊÖÊõ×éÖ»½øÐо±¶¯Âö½áÔú£¬²»½øÐÐÇòÄÒËðÉËÊõ£©£»¶ÔÕÕ×飺ÇòÄÒËðÉËÊõºó¾Ö²¿¹à×¢Lipofectamine 2000 Reagent+TE»º³åÒº£»ÖÎÁÆ×飺ÇòÄÒËðÉËÊõºó¾Ö²¿¹à×¢Lipofectamine 2000 Reagent +TE»º³åÒº+pCAGGS-GFP/A20ÖØ×éÖÊÁ£¡£A20ÖÊÁ£DNAÔÚÇòÄÒËðÉË´óÊó¾±¶¯ÂöµÄ¾Ö²¿×ªÈ¾¡£¢ÛʵÑéÆÀ¹À£ºÓ«¹âÏÔ΢¾µ¹Û²ìA20ÔÚËðÉ˶¯Âö±ÚµÄתȾЧÂÊ£»ÒÁÎÄ˼À¶È¾É«·¨ÆÀ¹ÀËðÉ˺󾱶¯ÂöÄÚÆ¤ÔÙÉúÇé¿ö£»Í¸Éäµç¾µ¹Û²ìѪ¹Ü³¬Î¢½á¹¹¸Ä±ä¡£ÊµÑé¹ý³Ì¶Ô¶¯ÎïµÄ´¦Àí·ûºÏ¶¯ÎïÂÛÀíѧ±ê×¼¡£
½á¹û£º¢ÙÇòÄÒËðÉËÊõºÍA20תȾÖÎÁƺó2ÖÜ£¬ÖÎÁÆ×éÔÙÄÚÆ¤»¯°Ù·Ö±È´óÓÚ¶ÔÕÕ×飨P < 0.05£©¡£¢Ú¼ÙÊÖÊõ×é´óÊó¾±¶¯Âöƽ»¬¼¡Ï¸°ûµç¾µÏ³ʵäÐ͵ġ°ÊÕËõ±íÐÍ¡±£»¶ÔÕÕ×éÇòÄÒËðÉ˺ó3 d¿É¼ûºÏ³ÉÐÍϸ°û¼°¹ý¶ÉÐÍϸ°û£¬7 dѪ¹Üƽ»¬¼¡Ï¸°û±íÐÍ·¢ÉúÃ÷ÏԸı䣬³ÊµäÐ͵ġ°ºÏ³É±íÐÍ¡±£¬ÖÎÁÆ×éÊõºó7 d¿É¼û½Ó½üÊÕËõÐ͵ÄѪ¹Üƽ»¬¼¡Ï¸°û¡£
½áÂÛ£º¾Ö²¿×ªÈ¾A20»ùÒò¿É´Ù½øËðÉËѪ¹ÜÄÚÆ¤ÔÙÉú£¬ÒÖÖÆËðÉË´¦Ñª¹Üƽ»¬¼¡Ï¸°û±íÐÍת»¯¡£
¹Ø¼ü´Ê£ºÐ¿Ö¸µ°°×A20£»ÄÚÆ¤£»³¬Î¢½á¹¹£»»ùÒòתȾ£»´óÊóÿÿÿÿ

¸ß¾²£¬ÀîÀÙ£¬Ð쵤£¬³ÂÁ¼£¬ÇúÅô. ´óÊó¾±¶¯ÂöÇòÄÒËðÉ˾ֲ¿A20»ùÒòתȾºóÄÚÆ¤Ï¸°ûÔÙÉú¼°Ñª¹Ü³¬Î¢½á¹¹µÄÓ°Ïì[J].Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´£¬2008£¬12(15):2838-2842 [www.zglckf.com/zglckf/ejournal/upfiles/08-15/15k-2838(ps).pdf]

´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÐÄÄÚ¿Æ£¬ÁÉÄþÊ¡´óÁ¬ÊÐ 116027

¸ß ¾²¡î£¬Å®£¬1979ÄêÉú£¬É½¶«Ê¡Æ½Ô­ÏØÈË£¬ºº×壬´óÁ¬Ò½¿Æ´óѧÔÚ¶Á²©Ê¿£¬Ö÷Òª´ÓʽéÈëÐÄÔಡѧµÄÑо¿¡£
slgaojing@sohu.
com

ͨѶ×÷ÕߣºÇú Åô£¬²©Ê¿£¬²©Ê¿Éúµ¼Ê¦£¬´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÐÄÄÚ¿Æ£¬ÁÉÄþÊ¡´óÁ¬ÊÐ 116027
qupeng777@yahoo.
com.cn

¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð×ÊÖúÏîÄ¿£¨30670836£© *

ÖÐͼ·ÖÀàºÅ:R329.412
ÎÄÏ×±êʶÂë:B
ÎÄÕ±àºÅ:1673-8225
(2008)15-02838-05

ÊÕ¸åÈÕÆÚ£º2007-09-25 ÐÞ»ØÈÕÆÚ£º2007-01-04 (07-50-9-5250/W¡¤Q)


Effects of zinc finger protein A20 on reendothelialization and vascular ultrastructure of rats with carotid artery balloon injury

Abstract

AIM: Zinc finger protein A20 is the activated product of nuclear factor-¦ÊB signaling. Activation of nuclear factor-¦ÊB is one of important mechanisms of angiostegnosis after balloon injury. This study aimed to investigate the effects of in vivo local transfection of zinc finger protein A20 gene on reendothelialization and vascular ultrastructure of rats with carotid artery balloon injury.
METHODS: Experiments were performed at the Central Laboratory of Second Affiliated Hospital of Dalian Medical University from March 2006 to June 2007.¢ÙForty-two healthy male Sprague-Dawley (SD) rats of 350-400 g were selected. ¢ÚThe rats were randomly divided into three groups equally. A20 plasmid DNA was prepared. Rat models of common carotid artery balloon injury were established. Rats in the sham operation group only received ligation of carotid. Rats in the control group were administered with Lipofectamine 2000 Reagent+TE buffer solution in local region after sac injury. Rats in the treatment group were treated with Lipofectamine 2000 Reagent +TE buffer solution+pCAGGS-GFP/A20 recombinant plasmid after sac injury. A20 plasmid DNA was locally transferred into rats with carotid balloon injury. ¢ÛThe transfection efficiency of A20 plasmid in injured arterial wall was evaluated by fluorescence microscope. Endothelial regeneration of corotid artery was evaluated by Evans blue dye staining. Ultrastructural change in injured artery was observed with a transmission electron microscope. The disposal in animals was accorded with the animal ethical standards.
RESULTS: ¢ÙLocal transfection of A20 gene resulted in an increase in reendothelialization, as measured as percent area reendothelialized at day 14 in the treatment group compared to the control group (P < 0.05). ¢ÚContractile phenotype of vascular smooth muscle cells (VSMCs) was shown in the sham operation group and synthetic phenotype and transition cells were shown after balloon injury in the control group at day 3. VSMCs showed typical synthetic phenotype at day 7, at the same time, VSMCs resembled contractile phenotype in the treatment group at day 7.
CONCLUSION: Local transfection of A20 gene can accelerate reendothelialization after arterial injury and inhibit the phenotype transformation of VSMCs.

Gao J, Li L, X¨¹ D, Chen L, Qu P. Effects of zinc finger protein A20 on reendothelialization and vascular ultrastructure of rats with carotid artery balloon injury.Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu 2008;12(15):2838-2842(China) [www.zglckf.com/zglckf/ejournal/upfiles/08-15/15k-2838(ps).pdf]

Department of Cardiology, Second Affiliated Hospital, Dalian Medical University, Dalian 116027, Liaoning Province, China

Gao Jing¡î, Studying for doctorate, Department of Cardiology, Second Affiliated Hospital, Dalian Medical University, Dalian 116027, Liaoning Province, China
slgaojing@sohu.com

Correspondence to: Qu Peng, Doctor, Tutor of doctor, Department of Cardiology, Second Affiliated Hospital, Dalian Medical University, Dalian 116027, Liaoning Province, China
qupeng777@yahoo.
com.cn

Supported by: the National Natural Science Foundation of China, No. 30670836*

Received: 2007-09-25
Accepted: 2008-01-04

Advertisement

¡¶Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´¡·ÔÓÖ¾Éç
µØÖ·£ºÉòÑô1200ÓÊÕþÐÅÏä Óʱࣺ110004 ´«Õ棺+86 24 23394178